JS
James Spicer
King's College London
Research areas: Medicine · Pulmonary and Respiratory Medicine · Cancer Immunotherapy and Biomarkers · Lung Cancer Treatments and Mutations · Lung Cancer Diagnosis and Treatment
0000-0003-3732-8491
Employment
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (222)
- Oncology drug development in the UK Save
- Preclinical characterization and phase 1 clinical testing of targeting mitochondrial peroxiredoxin 3 in cancer Save
- Dendrimer-nanoparticle (DEP) delivery of cabazitaxel (DEP-cabazitaxel) Save
- Safety and activity of RO7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with advanced solid tumors Save
- AllergoOncology Save
- Independent Testing of Published CT Models for PD-L1 Status in Non-Small Cell Lung Cancer Save
- AllergoOncology in Review: Harnessing Allergy in the Field of Oncology to Improve Patient Outcomes Save
- Predictors and Outcomes of Non-Small Cell Lung Carcinoma Patients Following Severe Immune Checkpoint Inhibitor Toxicity Save
- An oral heme oxygenase inhibitor targets immunosuppressive perivascular macrophages in preclinical models of cancer Save
- Non-Allergic Urticarial Skin Reactions Associated With MOv18 IgE, a First-In-Class IgE Antibody Recognising Folate Receptor Alpha Save
- Tumor microenvironments with an active type I IFN response are sensitive to inhibitors of heme degradation Save
- PD-L1 imaging with [99mTc]NM-01 SPECT/CT is associated with metabolic response to pembrolizumab with/without chemotherapy in advanced lung cancer Save
- Assessment of biophysical properties of the first-in-class anti-cancer IgE antibody drug MOv18 IgE demonstrates monomeric purity and stability Save
- A Retrospective Evaluation of PD-L1 Expression and Heterogeneity in Early-Stage Non-Small Cell Lung Cancer (REPLICA) Save
- Corrigendum to ‘A Phase Ib, Open-Label Trial Of MOv18 IgE In Patients With Advanced Ovarian Cancer’ [International Journal of Gynecological Cancer Volume 35, Issue 2 Supplement 1 (2025) #809] (International Journal of Gynecological Cancer (2025) 35(2S1),… Save
- Hyperinflammatory repolarisation of ovarian cancer patient macrophages by anti-tumour IgE antibody, MOv18, restricts an immunosuppressive macrophage:Treg cell interaction Save
- A phase II trial of mTORC1/2 inhibition in STK11 deficient non small cell lung cancer Save
- Long term efficacy of first-line afatinib and the clinical utility of ctDNA monitoring in patients with suspected or confirmed EGFR mutant non-small cell lung cancer who were unsuitable for chemotherapy Save
- Physiochemical and functional evaluation of the first-in-class anti-cancer IgE antibody drug, MOv18, through process development and good manufacturing practice production Save
- Phase Ib Study of the Immunocytokine Simlukafusp Alfa (FAP-IL2v) in Combination with Cetuximab in Patients with Head and Neck Squamous Cell Carcinoma Save